Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatments
Pfizer's CEO Albert Bourla is trying to reposition the global pharmaceutical giant for a post-pandemic world.
Puerto Rico is entangled in a heated public health debate over vaccines and masks
A fiery debate over public health and personal rights has gripped Puerto Rico as legislators clash with medical experts.
Texas attorney general sues Pfizer, claiming vaccines didnโt end pandemic quickly enough
Experts argue other assertions made in the lawsuit filing are completely unsubstantiated, such as one claiming that vaccinated people were more likely to die from COVID-19, which Texas health data disputes.
Booking a COVID-19 vaccine? Some are reporting canceled appointments or insurance issues
Pfizer and Moderna say they have sent out millions of doses of the new COVID-19 vaccines in the past week.
Tornado damage to Pfizer plant will probably create long-term shortages of some drugs hospitals need
U.S. hospital drug supplies may be strained further after a tornado ripped open the roof of a Pfizer factory this week.
Tornado damages Pfizer plant in North Carolina as scorching heat and floods sock other parts of US
A tornado has heavily damaged a major Pfizer pharmaceutical plant in North Carolina โ the latest in a string of extreme weather events plaguing the U.S. Torrential rains flooded communities in Kentucky while an area from California to South Florida endured more blistering heat on Wednesday.
FDA advisers back RSV vaccine for pregnant women that protects their newborns
Federal health advisers are backing a first-of-its-kind RSV vaccine to protect newborns by immunizing their moms late in pregnancy.
Bexar County officials continue to see low turnout for updated booster vaccine
Data from the San Antonio COVID-19 Dashboard shows us that only 15.1 percent of people in Bexar County have the updated booster.
FDA panel narrowly backs Pfizer RSV vaccine for older adults
Federal health advisers have narrowly backed an experimental vaccine from Pfizer that could become the first shot to protect older adults against the respiratory illness known as RSV.
Pfizer's Paxlovid not included in China's national insurance
China will not include Pfizerโs COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price, saying it was too expensive.
Stocks end lower as hot jobs data signals aggressive Fed
Stocks gave up early gains and ended lower on Wall Street after an unexpectedly strong report on the job market raised concerns that the Federal Reserve will need to keep the pressure on inflation with aggressive interest rate increases.
Audit hits N. Dakota on vaccine handling; agency disputes it
A state audit says the North Dakota Health Department stored thousands of COVID-19 vaccine doses at incorrect temperatures or without temperature data over the past two years โ and that some of the vaccine was administered to patients.
EU regulator clears Pfizer-BioNTech's tweaked COVID booster
The European Medicines Agency has recommended the authorization of a tweaked booster dose of the Pfizer-BioNTech coronavirus vaccine that includes protection against two of the latest versions of omicron, as countries look to bolster their immunization programs ahead of winter.
University Health to begin offering Pfizer-BioNTech bivalent COVID-19 vaccine next week
University Health will begin offering the Pfizer-BioNTech bivalent COVID-19 vaccine starting Tuesday to provide a new layer of protection against the Omicron variant.
Metro Health Clinics will not offer COVID-19 boosters until new versions become available
Updated COVID-19 booster shots are expected to roll out soon, which is why the San Antonio Metropolitan Health District is no longer offering the original boosters to anyone 12 years old or older.
EU regulator clears tweaked versions of COVID vaccines
The European Medicines Agency has recommended the authorization of two coronavirus vaccines made by Pfizer-BioNTech and Moderna Inc., tweaked to include protection against an early version of the omicron variant.
Pfizer asks EU drug regulator to OK tweaked COVID vaccine
Pharmaceuticals Pfizer and BioNTech say they have asked the European Medicines Agency to authorize their updated coronavirus booster vaccine that includes the most recent omicron subvariants.
Questions about new COVID-19 recommendations, vaccines and boosters? University Health epidemiologist has answers
University Health director of hospital epidemiology Dr. Jason Bowling answers some of the most frequently asked questions about COVID-19, boosters, new vaccines and new CDC recommendations.
Texans have been slow to vaccinate their youngest against COVID-19, but theyโre slightly ahead of the national average
For some parents of kids under 5 who want to vaccinate them, the wait has been excruciating, fraught with delays and close calls. Others are hesitant to have their young children vaccinated.
FDA advisers recommend updating COVID booster shots for fall
Government advisers are recommending that some U.S. adults get a modified COVID-19 booster shot this fall โ one that better matches more recent virus variants.
US grapples with whether to modify COVID vaccine for fall
U.S. health authorities are facing a critical decision: whether to offer new COVID-19 booster shots this fall that are modified to better match the latest changes of the shape-shifting coronavirus.
US: Pfizer COVID-19 shot appears effective for kids under 5
A review by federal health officials says that Pfizer's COVID-19 vaccine appears safe and effective for children under 5, the only group not currently eligible for vaccination.
White House: 1st shots for kids under 5 possible by June 21
The Biden administration says children under 5 may be able to get their first COVID-19 vaccination doses as soon as June 21, if federal regulators authorize shots for the age group as expected.
Rare cases of COVID returning pose questions for Pfizer pill
A small number of COVID-19 patients are relapsing after taking Pfizer's antiviral pill, raising questions about the drug at the center of the U.S. response effort.
COVID shots still work but researchers hunt new improvements
COVID-19 vaccines still offer strong protection against severe illness and death, but Moderna and Pfizer are testing combination shots as a possible new kind of booster.
EU regulator starts reviewing Spanish COVID vaccine booster
The European Union's drug regulator says it has begun an accelerated review process for an experimental coronavirus vaccine booster made by the Spanish company Hipra.
EXPLAINER: What to know about COVID vaccines for little kids
Moderna says it will ask regulators to authorize its COVID-19 vaccine for children under 6 but several hurdles need to be cleared before the shots could become available.
EU clears Moderna shot for young kids, Pfizer boosters
The European Medicines Agency said it has authorized Modernaโs coronavirus vaccine for children aged six to 11, in addition to recommending booster shots of Pfizerโs vaccine for those aged 12 and over.